Advancing CMC Workshop

Overview

This workshop will focus on current challenging topics in chemical manufacturing and controls (CMC) within the global pharmaceutical/ biopharmaceutical arena, such as Accelerated Development Programmes, Global Regulatory Convergence, and new & future ICH topics. The format will allow participants to engage in constructive dialogue with experts from Regulatory Agencies and Industry, enabling interactive cross-functional discussions.

Who should attend?

CMC Regulatory Affairs
CMC Writing
CMC policy
Global Development
Quality Assurance/Quality Control
Regulatory Compliance
API Development and ManufacturingS1S
Technical Research and Development
ICH Guidelines Implementation and Development
Formulation Development and Manufacturing
Analytical Development
CMC Lifecycle Management
CMC Project Management
Medical Devices and Combination Products
All professionals involved in CMC

Learning objectives

Understand how the companies and regulators deal with challenges for CMC in accelerated development programmes for biological and chemical molecules
Gain insights of current CMC trends from international Regulators and their efforts to simplify the regulatory frameworks
Have a clear overview on global/ regional harmonisation initiatives and how they drive regulatory convergence

Program Committee

Frank Montgomery, PhD • Global Head Regulatory CMC, GRAPSQA
AstraZeneca, United Kingdom
Helen L Fitton • Vice President Regional Regulatory Affairs (Pharma)
GlaxoSmithKline, United Kingdom
Susanne Ausborn, PhD • Regulatory Policy Lead
F. Hoffmann-La Roche Ltd, Switzerland
Sylvie Meillerais, MSc • Director Regulatory Policy
MSD (Europe) Inc., Belgium
Ursula Busse, PhD, MBA • Global Head of Quality Intelligence & External Affairs
Novartis, Switzerland